Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Genomic Landscape of Ceritinib
- Status
- TERMINATED
- Phase
- N/A
Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Rociletinib (CO-1686) USA Expanded Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
MPDL3280A With Chemoradiation for Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tumor-specific T Cells in Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
- Status
- UNKNOWN
- Phase
- PHASE4